LifeX to Regularly Hold AX and DX Seminars for the Pharmaceutical Industry

Introduces ways to streamline repetitive tasks with AI, drawing on RareNote’s operations
"Holding an additional seminar to reflect pharmaceutical companies’ needs"

LifeX, a company specializing in healthcare data, said on the 28th that it will regularly hold its “AX and DX Seminar for the Pharmaceutical Industry” to share ways to improve the operational efficiency of patient support programs (PSPs) using artificial intelligence (AI) and help pharmaceutical companies reduce their budgets.

Held online, the seminar provides a forum for sharing ways to use AI that reflect pharmaceutical professionals’ interests and on-the-ground needs. It began on September 8 and has been held three times to date, with 62 professionals from 26 domestic and international pharmaceutical companies taking part. Attendees included representatives from global pharmaceutical companies such as GSK, Novartis, Janssen, Ono Pharmaceutical, and Pfizer, as well as domestic companies such as JW Pharmaceutical, Boryung, Yuhan Corporation, and Hanmi Pharmaceutical.

AI autopilot demonstration screen at the LifeX pharmaceutical industry AX/DX seminar. LifeX

The third seminar, held on October 20, focused on “How to Use the 2027 Budget More Efficiently with AI: A Focus on PSPs.” Following inquiries from pharmaceutical company representatives about operating costs after the previous seminars, the session focused on changes to PSP operating costs following the adoption of AI and practical information needed to prepare 2027 budgets.

Drawing on its experience operating RareNote, a support service for patients with cancer and rare diseases, LifeX introduced ways to use AI to reduce the cost of repetitive tasks and reflect those savings in service fees. It also presented a service fee rate of about 1% of the support fund. Actual fees vary depending on the scale of the program and its specific operating conditions.

As a way to reduce operating costs, LifeX proposed using AI to make document reviews more efficient. LifeX’s AI Autopilot cross-checks application information, submitted documents, and previous support records to assist staff with their reviews. Staff make the final decision on whether to approve or reject an application. This approach reduces the time and cost of repetitive tasks while maintaining existing patient support criteria.

LifeX said seminar participants showed interest in using AI Autopilot to make repetitive tasks more efficient. In particular, they focused on ways to reduce operating costs while maintaining the accuracy of patient support.

LifeX plans to hold a fourth encore seminar reflecting the practical needs of pharmaceutical companies and continue its AX and DX seminars. It also plans to offer separate consultations to review the operating methods and costs of individual PSPs.

“We wanted to offer practical ways for pharmaceutical companies preparing their 2027 budgets to reduce the burden of operating costs while maintaining the quality of patient support,” said Jang Minhu, CEO of LifeX. “We will continue to develop concrete ways to improve PSP operating efficiency using AI and support pharmaceutical companies in applying them in practice.”

This content was produced with the assistance of AI translation services.